Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Wang H, Tran TT, Duong KT, Nguyen T, Le UM
One dynamic that we and investors will be closely monitoring is the potential tailwind to branded GLP-1 drugs for obesity when compounded versions can no longer be sold in the US, as of May 22, 2025
Many plans cover Mounjaro for type 2 diabetes maintenance but not Zepbound for weight management beyond an initial period
It is more stable in
US$ 24.80
US$ 28.37
US$ 24.62
US$ 29.79
US$ 25.96
US$ 26.26
